Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eui-Cheol Shin

Showing results (1-10 of 376) with videos related to

Pageof 38
Sort By:
The Korean Journal of Hepatology|June 29, 2006
[Immunology of hepatitis C: clinical significance of T cell response]Eui-Cheol Shin
BMB Reports|January 7, 2021
Cancer immunotherapy: special issue of BMB Reports in 2021Eui-Cheol Shin
Molecules and Cells|June 30, 2021
Scientific Understanding of COVID-19: The First Step to Vanquishing the Current PandemicEui-Cheol Shin
Immune Network|March 12, 2020
Coalition Forces of Immunologists and Oncologists for Defeating CancerEui-Cheol Shin
Yonsei Medical Journal|October 27, 2011
Clinical implications of chemokines in acute and chronic hepatitis C virus infectionWonseok Kang, Eui-Cheol Shin
Nature Medicine|March 8, 2006
Taking the brake off T cells in chronic viral infectionEui-Cheol Shin, Barbara Rehermann
Yonsei Medical Journal|April 28, 2021
Roles of Type I and III Interferons in COVID-19Hojun Choi, Eui Cheol Shin
BMB Reports|December 14, 2021
Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approachesHojun Choi, Eui-Cheol Shin
Plos One|September 1, 2012
Colorimetric focus-forming assay with automated focus counting by image analysis for quantification of infectious hepatitis C virionsWonseok Kang, Eui-Cheol Shin
Hepatology (Baltimore, Md.)|March 5, 2024
Duet of humoral and cellular immunity for conquering HCVHosun Yu, Eui-Cheol Shin
Pageof 38

Showing results (1-10 of 376) with videos related to

Sort By:
Pageof 38
The Korean Journal of Hepatology|June 29, 2006
[Immunology of hepatitis C: clinical significance of T cell response]Eui-Cheol Shin
BMB Reports|January 7, 2021
Cancer immunotherapy: special issue of BMB Reports in 2021Eui-Cheol Shin
Molecules and Cells|June 30, 2021
Scientific Understanding of COVID-19: The First Step to Vanquishing the Current PandemicEui-Cheol Shin
Immune Network|March 12, 2020
Coalition Forces of Immunologists and Oncologists for Defeating CancerEui-Cheol Shin
Yonsei Medical Journal|October 27, 2011
Clinical implications of chemokines in acute and chronic hepatitis C virus infectionWonseok Kang, Eui-Cheol Shin
Nature Medicine|March 8, 2006
Taking the brake off T cells in chronic viral infectionEui-Cheol Shin, Barbara Rehermann
Yonsei Medical Journal|April 28, 2021
Roles of Type I and III Interferons in COVID-19Hojun Choi, Eui Cheol Shin
BMB Reports|December 14, 2021
Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approachesHojun Choi, Eui-Cheol Shin
Plos One|September 1, 2012
Colorimetric focus-forming assay with automated focus counting by image analysis for quantification of infectious hepatitis C virionsWonseok Kang, Eui-Cheol Shin
Hepatology (Baltimore, Md.)|March 5, 2024
Duet of humoral and cellular immunity for conquering HCVHosun Yu, Eui-Cheol Shin
Pageof 38